Skip to the page

Data / Form D filings / Solaris Vaccines, Inc.

Solaris Vaccines, Inc.: Form D filings

Solaris Vaccines, Inc., a company in Fort Collins, CO, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on May 19, 2023, reports $110,000 sold of a $200,000 offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
320 E. VINE DRIVE, SUITE 101, Fort Collins, CO, 80524
Phone
(479) 571-2592
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1903363

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 19, 2023New notice$200,000$110,000$90,0003May 12, 2023sec.gov
Jan 7, 2022New notice$500,000$500,0001Dec 27, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael Calvin ArtingerExecutive Officer, Director
Robert Calvin GoforthDirector

Other companies in Colorado that filed recently

Every Form D from the week of May 15, 2023 · All recent filings in Colorado · All recent Other filings

Read from SEC EDGAR. Amount sold is what Solaris Vaccines, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.